# INTERogating Cancer for Etiology, Prevention and Therapy Navigation

> **NCT06008392** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 500 (estimated)

## Conditions studied

- Cancer
- Cancer Gene Mutation
- PAN Gene Mutation
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **GENETIC:** Pan-genomic Testing

## Key facts

- **NCT ID:** NCT06008392
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-12
- **Primary completion:** 2033-09
- **Final completion:** 2033-09
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06008392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06008392, "INTERogating Cancer for Etiology, Prevention and Therapy Navigation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06008392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*